Scollr summary
What this paper is about
A single-molecule chemophototherapy (SM-CPT) approach based on computational screening of approved anticancer drugs for repurposing as photosensitizers is introduced, highlighting SM-CPT as a translationally attractive light-activated cancer therapy.
Full abstract
Read the full abstract
Abstract Chemophototherapy (CPT), combining chemotherapy and photodynamic therapy (PDT), is a promising strategy to enhance anticancer efficacy while reducing systemic toxicity. Many approved drugs contain chromophoric moieties that absorb visible light, suggesting their potential as intrinsic photosensitizers. Herein, we introduce a single-molecule chemophototherapy (SM-CPT) approach based on computational screening of approved anticancer drugs for repurposing as photosensitizers. A curated library of 238 small-molecule drugs was screened using time-dependent density functional theory to identify compounds with favourable photophysical properties. Fifteen candidates were identified, and mitoxantrone, pixantrone, daunorubicin, and epirubicin were selected for experimental validation. All compounds generated reactive oxygen species upon irradiation and showed enhanced cytotoxicity in breast cancer cell models, with up to an order-of-magnitude reduction in half-maximal inhibitory concentration values. The approach was further validated in ovarian cancer models, including platinum-resistant cells and patient-derived ascites, highlighting SM-CPT as a translationally attractive light-activated cancer therapy.
Direct answer
What can I do from this paper page?
Use this page to scan "Repurposing Approved Chemotherapeutics as Intrinsic Photosensitizers for Single-Molecule Chemophototherapy" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Photodynamic Therapy Research Studies, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Greco2026Repurposing,
title = {Repurposing Approved Chemotherapeutics as Intrinsic Photosensitizers for Single-Molecule Chemophototherapy},
author = {Giulia Greco and Giulia Giugliano and Alessia Marconi and Paolo Emidio Costantini and Michele Trivini and Giulia Neggiani and Francesca Maffei and Manuele Di Sante and Tainah Dorina Marforio and Alessandro Calza and Manuela Sollazzo and Anna Maria Porcelli and Giuseppe Gasparre and Francesco Zerbetto and Alberto Danielli and Julia Westermayr and Matteo Di Giosia and Carmela Fimognari and Eleonora Turrini and Edoardo Jun Mattioli and Matteo Calvaresi},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02353},
url = {https://doi.org/10.1021/acs.jmedchem.6c02353}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Photodynamic Therapy Research Studies papers?
Follow Photodynamic Therapy Research Studies in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Repurposing Approved Chemotherapeutics as Intrinsic Photosensitizers for Single-Molecule Chemophototherapy. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app